- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06160882
Powered Prosthesis for Use with TF Osseointegration Recipients
Evaluation of Powered Prosthesis for Use with Transfemoral Osseointegration Recipients
Study Overview
Status
Conditions
Detailed Description
The objective of this study is to evaluate functional mobility, non-weight-bearing neural control, and user satisfaction from individuals with unilateral transfemoral amputation who have received osseo-integration (OI) and targeted muscle reinnervation (TMR), while ambulating with a fully powered prosthesis.
The hypothesis is that OI will show perceived benefits for participants including: 1) lower perceived weight of the prosthesis due to the more secure OI interface over a traditional socket, 2) decreased energy expenditure during ambulation and transitions, and 3) electromyographic (EMG) signals will be higher quality and more robust than signals measured from within a socket, potentially allowing for improved pattern recognition driven prostheses in future device design and studies.
Prior to surgical intervention, amputee participants will visit the lab up to 3 times for socket fitting, and at most 7 times to practice using the powered prosthesis and collect experimental data. There is no time limitation between sessions and each session will last a maximum of 4 hours.
Aim 1: Pre-Surgery Fitting and Powered Leg Prosthesis Training:
Participants will be fit for a custom instrumented socket that allows for collection of surface EMG signals and for use with the powered lower limb prosthesis. The socket that is fabricated is solely for the purpose of this study, will be used only in the research lab. The participant will continue to use their clinically prescribed socket and prosthesis when not attending study visits. EMG control sites over the semitendinosus, biceps femoris, tensor fasciae latae, rectus femoris, vastus lateralis, and adductor magnus will be located using clinical best practices. Once socket fit is completed, the prosthetist will attach and align the powered prosthesis. The participant will be instructed to walk with the powered prosthesis for level ground walking, incline walking, stair climbing and non-weight bearing independence control activities. The walkway, ramps and stairs are equipped with handrails and the amputee with be wearing either an overhead harness or gait belt for safety. Additionally, a non-weight bearing independent control system will be configured. The participant will be instructed to attempt to move their 'phantom' limb through knee flexion/extension and ankle plantarflexion/dorsiflexion range movements while EMG data are collected. These data are used to train a pattern recognition control system which can control the leg knee and ankle joints respectively, either in a virtual environment or with the physical prosthesis. The participants will then complete functional, biomechanical, metabolic, and qualitative patient reported outcome measures using the instrumented socket and the powered leg prosthesis. The investigator will use an extensive list of standard clinical assessments and participant-reported measures that assess physical function, mobility, balance, fall risk, quality of life, and metabolic expenditure.
OI TMR surgery 1 and recovery: participants will undergo the first osseointegration (OI) and targeted muscle reinnervation (TMR) surgery at Northwestern Memorial Hospital.
OI surgery 2 and recovery: Participants will undergo the second OI surgery where the abutment will be connected to the fixture with in the femur. The participant will again be monitored for full recovery (typically 4-6 weeks). No outcome measures or assessments will be performed prior to 12 weeks' post-surgery
Aim 2: Post-Surgery Fitting and Powered Leg Prosthesis Training:
After osseointegration and TMR surgery and recovery, the study participant no longer requires a standard prosthetic socket. EMG signals can now be measured using a custom fit electrode band on the residual limb that is tethered to the prosthesis. Participants will be fit with the powered prosthesis using their OI interface and trained on its use. Participants will receive instruction on use of the powered prosthesis, now attached via their OI interface with the electrode band. The participants will walk under the supervision of a clinician while device parameters are configured as prior to OI/TMR surgery. The participant will progress to walking over slopes, perform stairclimbing with a reciprocal gait and sit to and from standing transitions. The clinician will provide verbal instruction and cues on how to best make use of the power and how to safely perform all activities. The investigators will repeat the same measures as previously performed to evaluate the functional, metabolic, and biomechanical benefits conferred by OI over a traditional socket when using a powered leg device. At the end of each visit, the study participant will return to their clinically prescribed prosthesis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Suzanne Finucane, MS, PTA
- Phone Number: 312-238-0937
- Email: sfinucane@sralab.org
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Shirley Ryan Abilitylab
-
Contact:
- Suzanne Finucane
- Phone Number: 3122380937
- Email: sfinucane@sralab.org
-
Contact:
- Levi Hargrove, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Unilateral lower limb amputation at the transfemoral level
- Existing prosthesis wearer
- K2/K3/K4 level ambulation
- 18-70 years old
- Mini-Mental State Exam (MMSE) score greater than 17
- Ability to demonstrate proper safety with passive prosthesis
- Candidate for a myoelectric prosthesis (can generate mV level electromyographic EMG signals as detected by surface electrodes
- Candidate for OI surgery as verified by surgical team or has previously received OI
- Candidate for TMR surgery as verified by surgical team or has previously received TMR
Exclusion Criteria:
- Unable to successfully receive osseointegration and TMR
- Significant new injury that would prevent use of a prosthesis: Ability to consistently wear prosthesis and perform activities of daily living and specific performance tasks is necessary to properly evaluate the relative benefits of the intervention
- Cognitive impairment sufficient to adversely affect understanding of or compliance with study requirements, ability to communicate experiences, or ability to give informed consent: The ability to understand and comply with requirements of the study is essential in order for the study to generate useable, reliable data.
- Visually impaired
- Proximal nerve injury that prevents TMR
- Individuals who smoke: may interfere with OI process from both bone healing and soft tissue standpoints
- Individuals with active implants.
- Significant comorbidity that would preclude completion of the study, use of prostheses, or would otherwise prevent data acquisition by researchers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Evaluation of Powered Prosthesis for use with Transfemoral Osseointegration Recipients
Perform Osseointegration (OI)Surgery and Targeted Muscle Reinnervation (TMR) and evaluate powered prosthesis training and use.
The participant will complete non-weightbearing neural control tasks along with functional, biomechanical, metabolic and qualitative patient-reported outcome measures using the OI interface and the powered leg prosthesis.
|
Participants are fit for a custom instrumented socket for collection of surface EMG signals and use with the powered lower limb prosthesis. EMG control sites will be located using clinical best practices. Once socket fit is completed, the prosthetist will attach and align the powered prosthesis. The participant will be instructed to walk with the powered prosthesis for level ground walking, incline walking, stair climbing and non-weight bearing independence control activities. A non-weight bearing independent control system will be configured. These data are used to train a pattern recognition control system which can control the leg knee and ankle joints respectively, either in a virtual environment or with the physical prosthesis The participants will complete functional, biomechanical, metabolic, and patient reported outcome measures. Participants will undergo OI Surgery 1 +TMR and recovery. Following recovery, participants will receive OI surgery 2 where the abutment is connected to the fixture with in the femur. Participants will receive standard post-surgical care and participate in the OPRA rehab program through the Shirley Ryan AbilityLab. The participant uses their clinically prescribed prosthetic knee unit for training in the OPRA rehab program. Post-Surgery Fitting and Powered Leg Prosthesis Training: EMG signals are measured using a custom fit electrode band on the residual limb that is tethered to the prosthesis. Participants are fit with the powered prosthesis using their OI interface and trained on its use. The participant will complete non-weight-bearing neural control tasks as done prior to surgery. The participants will complete functional, biomechanical, metabolic, and patient-reported outcome measures using the OI interface and the powered leg prosthesis. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amputee Mobility Predictor with Prosthesis (AMPPRO)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
A questionnaire that measures the ambulatory potential of lower limb amputees.
It requires the amputee to complete various tasks.
Including sitting balance, reaching, transfers, sit to stand, and standing balance.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Amputee Mobility Predictor with Prosthesis (AMPPRO)
Time Frame: Completion of study, an average of 1 year from enrollment
|
A questionnaire that measures the ambulatory potential of lower limb amputees.
It requires the amputee to complete various tasks.
Including sitting balance, reaching, transfers, sit to stand, and standing balance.
|
Completion of study, an average of 1 year from enrollment
|
|
Six Minute Walk Test (6MWT)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The 6 minute walk test (6MWT) assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Six Minute Walk Test (6MWT)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The 6 minute walk test (6MWT) assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
|
Completion of study, an average of 1 year from enrollment
|
|
Timed Up and Go (TUG)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Timed Up and Go (TUG)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults.
|
Completion of study, an average of 1 year from enrollment
|
|
Single Leg Stance Test (SLS)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The Single Leg Stance (SLS) Test is used to assess static postural and balance control.
The SLS Test is a balance assessment that is widely used in clinical settings to monitor neurological and musculoskeletal conditions.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Single Leg Stance Test (SLS)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The Single Leg Stance (SLS) Test is used to assess static postural and balance control.
The SLS Test is a balance assessment that is widely used in clinical settings to monitor neurological and musculoskeletal conditions.
|
Completion of study, an average of 1 year from enrollment
|
|
Berg Balance Scale (BBS)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
It does not include the assessment of gait.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Berg Balance Scale (BBS)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The Berg Balance Scale (BBS) is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.
It does not include the assessment of gait.
|
Completion of study, an average of 1 year from enrollment
|
|
Four Square Step Test (FSST)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The Four Square Step Test (FSST) is used to assess dynamic stability and co-ordination.
It looks at the ability of the subject to step over low objects forward, sideways, and backward.[
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Four Square Step Test (FSST)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The Four Square Step Test (FSST) is used to assess dynamic stability and co-ordination.
It looks at the ability of the subject to step over low objects forward, sideways, and backward.[
|
Completion of study, an average of 1 year from enrollment
|
|
Prosthetic Limb Users Survey of Mobility (PLUS-M)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The Prosthetic Limb Users Survey of Mobility™ is a self-report instrument for measuring mobility of adults with lower limb amputation.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Prosthetic Limb Users Survey of Mobility (PLUS-M)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The Prosthetic Limb Users Survey of Mobility™ is a self-report instrument for measuring mobility of adults with lower limb amputation.
|
Completion of study, an average of 1 year from enrollment
|
|
Prosthesis Evaluation Questionnaire (PEQ)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The PEQ is a self-evaluating instrument consisting of nine validated scales: ambulation, appearance, frustration, perceived response, stump health, social burden, noise, utility, and well-being.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Prosthesis Evaluation Questionnaire (PEQ)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The PEQ is a self-evaluating instrument consisting of nine validated scales: ambulation, appearance, frustration, perceived response, stump health, social burden, noise, utility, and well-being.
|
Completion of study, an average of 1 year from enrollment
|
|
Patient Reported Outcome Measure Information System (PROMIS)
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
The PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children.
It can be used with the general population and with individuals living with chronic conditions.
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Patient Reported Outcome Measure Information System (PROMIS)
Time Frame: Completion of study, an average of 1 year from enrollment
|
The PROMIS is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children.
It can be used with the general population and with individuals living with chronic conditions.
|
Completion of study, an average of 1 year from enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine changes in EMG signal quality and neural information resulting from OI and TMR as compared to an instrumented socket for control of a powered leg prosthesis.
Time Frame: Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
A non-weight bearing independent control system will be configured.
The participant will be instructed to attempt to move their 'phantom' limb through knee flexion/extension and ankle plantarflexion/dorsiflexion range movements while EMG data are collected.
These data are used to train a pattern recognition control system which can control the leg knee and ankle joints respectively, either in a virtual environment or with the physical prosthesis
|
Completion of Aim 1:approximately 10-12 weeks (10 in lab visits) from enrollment
|
|
Determine changes in EMG signal quality and neural information resulting from OI and TMR as compared to an instrumented socket for control of a powered leg prosthesis.
Time Frame: Completion of study, an average of 1 year from enrollment
|
A non-weight bearing independent control system will be configured.
The participant will be instructed to attempt to move their 'phantom' limb through knee flexion/extension and ankle plantarflexion/dorsiflexion range movements while EMG data are collected.
These data are used to train a pattern recognition control system which can control the leg knee and ankle joints respectively, either in a virtual environment or with the physical prosthesis
|
Completion of study, an average of 1 year from enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Levi Hargrove, PhD, Shirley Ryan Abilitylab
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STU00215805
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation
-
Shirley Ryan AbilityLabUniversity of AlbertaActive, not recruitingAmputation | Amputation; Traumatic, Hand | Amputation, Traumatic | Amputation; Traumatic, LimbUnited States
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAmputation | Amputation; Traumatic, Limb | Upper Limb Amputation at the Hand | Upper Limb Amputation at the WristUnited States
-
Medipol UniversityRecruitingEvaluation of Functionality of Amputees According to the Medicare Functional K Classification SystemAmputation | Amputation; Traumatic, Leg, LowerTurkey
-
Point DesignsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingAmputation; Traumatic, Hand | Amputation, CongenitalUnited States
-
Shirley Ryan AbilityLabRecruitingAmputation | Amputation, Traumatic | Amputation; Traumatic, Limb | Amputation of KneeUnited States
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Fondazione Don Carlo Gnocchi OnlusCompletedAmputation | Amputation; Traumatic, Leg, LowerItaly
-
Hacettepe UniversityCompleted
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedLower Limb Amputation Below Knee (Injury) | Amputation | Prosthesis User | Amputation; Traumatic, Leg, Lower | Limb; Absence, Congenital, Lower | Amputation StumpUnited States
Clinical Trials on Powered Prosthesis Training and EMG data collection
-
Northern Arizona UniversityNot yet recruitingAmbulation With the "Take Home" or Passive Prosthesis | Ambulation With the Motorized Prosthesis in the "Off" Configuration | Ambulation With the Motorized Prosthesis in the "Transparent" Condition | Ambulation With the Motorized Prosthesis in the "Powered" ConditionUnited States
-
University Hospital, Basel, SwitzerlandCompletedPatellar InstabilitySwitzerland
-
Shirley Ryan AbilityLabCompleted
-
Shirley Ryan AbilityLabActive, not recruitingTransfemoral AmputeesUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Tuen Mun HospitalEnrolling by invitationDialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis (DETECT-PD)Peritoneal Dialysis | End-Stage Kidney Disease | End Stage Renal Disease (ESRD) | End Stage Renal Failure on Dialysis | Peritoneal Dialysis Patients | End Stage Renal Disease on Dialysis (Diagnosis)Hong Kong
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Vanda PharmaceuticalsRecruitingSleep-wake Disorder in Blind IndividualsUnited States
-
GlaxoSmithKlineWithdrawnHuman Papillomavirus Infection